Abstract:Managers choose to spend corporate resources to purchase directors' and officers' liability insurance, which protects directors and officers from personal financial liability in lawsuits brought against the firm and its directors and officers. We investigate whether the amount of D&O insurance coverage chosen by managers of IPO firms, and the cost of that insurance, is related to post-IPO abnormal stock price performance. If managers of IPO firms are exploiting superior inside information in bringing their companies public when the expected offering price exceeds managers' private valuation estimate, we hypothesize that the amount of insurance coverage chosen will be related to the post-offering performance of the issuing firm's shares. We analyze a sample of 72 IPO firms that went public between 1992 and 1996 for which we have detailed proprietary information about the amount and cost of D&O liability insurance. Consistent with the hypothesis, we find a significant negative relation between the 3-year post-IPO stock price performance and the amount of insurance coverage in place at the IPO date. We also analyze the pricing of D&O insurance by the insurers. Insurers charge more for insurance purchases that are larger than would be predicted by observable business risk proxies. However, insurers pool all abnormal insurance purchases together in that they do not distinguish between those who buy abnormally large insurance based on anticipated poor performance and those who buy extra insurance for other reasons (e.g., abnormally high risk aversion). Insurers do, however, appear to charge more to firms that buy more insurance and are subsequently sued, indicating that insurers are able to identify and price abnormal litigation risk. We argue that, similar to insider securities transactions, D&O insurance decisions reveal the private information of managers. This provides some motivation to argue that disclosure of the details of D&O insurance decisions, as is required in some other countries, is valuable.

Firm–Specific Human Capital and Governance in IPO Firms: Addressing Agency and Resource Dependence Concerns

Do Private Equity Investors Conspire with Ultimate Owners in the IPO Process?

Do Political Connections Help Firms’ Accessing the IPO Market?

Internal Capital Allocation in IPOs and Corporate Innovation: the Moderating Role of Political Connections

Monitoring or Colluding: the Role of Venture Capital Investors in the IPO Process

Start-Up Investor Governance Case

Post-Ipo Governance: Venture Capitalists' Role in Real Options Exercise Decisions

Family Firm Governance and Financial Policy Choices in Newly Public Firms

"Ownership Transition, Managerial Short-Termism, and Exploratory Vs Exploitative Innovation Strategy"

Entrepreneurial Finance Meets Government Investment at Initial Public Offering: the Role of Minority State Ownership

How Costly is Follow-on Financing After Premature Going-public Decisions?

Ambiguous Signals and Information Asymmetry in the Initial Public Offering Process: Examining Ownership Concentration, Process Time, and Underpricing

Entrepreneurial Resources, Organizational Choices, and Competitive Outcomes

Managerial Opportunism? Evidence from Directors' and Officers' Insurance Purchases

Economic Determinants and Consequences of the Proactive Disclosure of Internal Control Weaknesses and Remediation Progress in IPOs

Community social capital, managerial opportunistic behavior, and information uncertainty in IPO firms

Corporate governance in immigrant-founded entrepreneurial firms: ownership heterogeneity and firm performance

Gender diversity at entrepreneurial firm IPOs: responding to changing societal norms

Startup Governance

IPO Valuation of Entrepreneurial Firms in China's New Growth Enterprise Market

ESG Disclosure and Idiosyncratic Risk in Initial Public Offerings